3-Hydroxybutyric acid from Selleck profiling identifies diagnostic serum metabolomic biomarkers in endometriosis
Copy code to add this image to your page
Endometriosis is a complex, estrogen-dependent inflammatory disorder defined by the ectopic implantation and proliferation of endometrial tissue outside the uterine cavity. Traditional clinical diagnosis relies heavily on invasive surgical procedures, such as diagnostic laparoscopy, often leading to substantial delays in disease identification and management. Consequently, identifying circulating, non-invasive molecular signatures capable of capturing the underlying pathological mechanics of endometriosis represents an urgent mandate in reproductive medicine and molecular pathology.
Recent investigations leveraging high-resolution proton nuclear magnetic resonance (1H-NMR) spectroscopy have delineated discrete alterations in the serum metabolome of individuals affected by severe endometriosis. Metabolic profiling of clinical serum specimens demonstrates profound systemic bioenergetic and metabolic dysregulation driven by chronic inflammatory signaling and reactive oxygen species (ROS) accumulation within the pelvic microenvironment. Among the identified metabolic perturbations, 3-Hydroxybutyric acid (BHB acid)—a primary short-chain hydroxy fatty acid and principal ketone body—exhibits marked elevation in patient serum relative to non-endometriosis control cohorts. Parallel metabolomic shifts include significant upregulation of serum glutamine alongside severe depletion of circulating tryptophan.
Mechanistically, the accumulation of 3-Hydroxybutyric acid (BHB acid) serves as an essential bioenergetic marker reflecting altered fatty acid beta-oxidation and mitochondrial strain. In healthy physiological states, 3-Hydroxybutyric acid functions as an alternative energy substrate synthesized in hepatic mitochondria from acetyl-CoA when carbohydrate availability is restricted. In the context of severe endometriosis, persistent microenvironmental inflammation and localized oxidative stress perturb mitochondrial electron transport chain efficiency, altering cellular nicotinamide adenine dinucleotide (NAD+/NADH) ratios. This oxidative burden shifts cellular energetic reliance toward secondary lipid oxidation and ketogenesis pathways. Utilizing high-purity analytical standards, such as 3-Hydroxybutyric acid from Selleck, researchers have validated these NMR spectral peaks, confirming that serum BHB acid elevation directly mirrors altered systemic bioenergetics and macrophage activation dynamics.
Simultaneously, the reciprocal shifts observed in glutamine and tryptophan levels highlight altered amino acid catabolism driven by immune activation. Glutamine serves as a critical nitrogen and carbon donor required for rapid immune cell proliferation and glutathione biosynthesis under oxidative stress conditions. Elevated serum glutamine indicates systemic compensatory mobilization to counteract microenvironmental inflammation. Conversely, the significant suppression of serum tryptophan aligns with indoleamine 2,3-dioxygenase (IDO) pathway hyperactivation, an enzymatic cascade upregulated by pro-inflammatory cytokines such as interferon-gamma (IFN-γ) and interleukin-6 (IL-6). Active tryptophan depletion mediated by IDO facilitates local immune tolerance and tissue remodeling within ectopic lesions.
To establish diagnostic utility, empirical evaluation of these serum biomarkers via receiver operating characteristic (ROC) curve analysis was conducted. Single-marker evaluation of BHB acid yielded an area under the curve (AUC) of 0.85, demonstrating robust diagnostic discrimination as an isolated metric. When combined into a multi-metabolite biomarker panel comprising 3-Hydroxybutyric acid, glutamine, and tryptophan, the diagnostic performance reached an AUC of 0.92, achieving a specificity of 100% and sensitivity ranging between 62% and 67% in patient cohort trials. These quantitative findings demonstrate that non-invasive serum metabolomic profiling accurately captures the systemic biochemical fingerprint of severe pelvic inflammation.
Metabolic Biomarker Evaluation and Diagnostic Performance
Copy code to add this image to your page
Chronic pelvic inflammation and oxidative stress in endometriosis shift cellular bioenergetics toward ketogenesis and altered amino acid flux. Elevated serum 3-Hydroxybutyric acid (BHB acid) reflects impaired mitochondrial beta-oxidation and energy stress. Concurrent glutamine accumulation and tryptophan depletion indicate systemic immune cell activation and cytokine-driven IDO pathway activity. Evaluating this three-metabolite panel yields high diagnostic specificity (100%) and an AUC of 0.92, framing circulating BHB acid as a key functional surrogate biomarker of microenvironmental metabolic dysregulation.
NMR Quantification Demonstrates Marked Ketone Accumulation in Serum
High-resolution proton magnetic resonance spectroscopy revealed distinct metabolic shifts. Analysis of serum specimens demonstrated a statistically significant accumulation of 3-Hydroxybutyric acid (BHB acid) alongside elevated glutamine levels in individuals diagnosed with severe endometriosis relative to asymptomatic controls. Tryptophan concentrations dropped markedly across the patient cohort. Utilization of high-purity reference compounds, such as 3-Hydroxybutyric acid from Selleck, enabled precise spectral assignment and absolute metabolite quantification within complex biofluid matrices. Mitochondrial strain accelerates hepatic ketogenesis under inflammatory drive. This shift in small-molecule profiles reflects systemic bioenergetic adaptations induced by chronic pelvic inflammation; local oxidative stress impairs standard oxidative phosphorylation, forcing cellular energetic dependence onto secondary ketogenesis routes.
Multivariate Biomarker Panel Yields Exceptional Diagnostic Specificity
Receiver operating characteristic analysis defined individual biomarker efficacy. Single-variable ROC evaluation of serum 3-Hydroxybutyric acid yielded an area under the curve of 0.85, confirming its independent capacity to discriminate severe disease phenotypes. Combining multiple metabolic parameters enhanced diagnostic accuracy. Integration of 3-Hydroxybutyric acid from Selleck validation data into a composite panel featuring glutamine and tryptophan elevated the cumulative diagnostic AUC to 0.92, achieving absolute specificity (100%) and clinical sensitivity between 62% and 67%. Non-invasive biofluid profiling circumvents surgical intervention risks. These empirical metrics establish circulating ketone and amino acid signatures as robust surrogate endpoints for monitoring pelvic microenvironmental remodeling without requiring exploratory laparoscopy.